Company / Free Cash Flow per Share
Mirum Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.14
FY2025
5-year range
-$4.34 / $1.14
FY2021-FY2025
Trend
+468.4%
vs FY2024
Sector context
#44 of 192
Health Care
What the data says
Free Cash Flow per Share changed +468% YoY in FY2025, a notable deviation from the 7-year average annual change of -19%.
Based on SEC 10-K filings.
1.14 in FY2025. Top quartile in the Health Care sector.
Improved from $-1.92 to $1.14 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 192This company $1.14 Sector average $3.32
▼
-65.8% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 468.4% year-over-year.
- Ranks #44 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.14 | +468.4% |
| FY2024 | $0.20 | +110.4% |
| FY2023 | -$1.92 | +55.7% |
| FY2022 | -$4.34 | -44.8% |
| FY2021 | -$3.00 | +15.2% |
| FY2020 | -$3.54 | -2.5% |
| FY2019 | -$3.45 | -732.1% |
| FY2018 | -$0.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026